IPAS770
Concessão de registro em designação
RPI 2893
16/06/2026
Voltar para busca
Dado oficial do INPI
ODYSSEUS
Sabia que essa marca já está registrada no Brasil?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Registro de marca em vigor (Madri)Tipo: VerbalEscritório: Brasil
Snapshot rápido
ODYSSEUS
ST13
BR500000501851447Classe
5, 9, 41, 42
Pedido
501851447
Registro
501851447
Andamento no INPI
- Depósito31/01/25
- Publicação05/08/25
- Exame
- Deferimento02/06/26
- Concessão
- Vigente31/01/35
Registro concedido e em vigor até 31/01/2035, quando precisa ser renovado.
Proteção válida até:31/01/2035
Última movimentação publicada pelo INPI: 16/06/2026. Atualizamos a cada nova RPI, publicada semanalmente.
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação INPI
Registro de marca em vigor (Madri)
Tipo de processo
Pedido de registro
Eventos registrados
4
Atualização mais recente
16/06/2026
Tipo de marca
Verbal
Classes Nice
5, 9, 41, 42
Data de depósito
31/01/2025
Data de registro
-
Data de expiração
31/01/2035
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Natureza
Madri Produto/Serviço
Escritório responsável
Brasil
Tipo de titular
NÃO RESIDENTE
Localização do titular
GB
Titulares e representantes
Titulares
Trogenix Ltd
Representantes
Sem dados de representantes.
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 41Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical, medical or veterinary preparations and substancesRNA therapeuticspharmaceutical preparations for use in targeted pharmaceutical therapiespharmaceutical preparations and products for the treatment of neoplastic diseasespharmaceutical preparations and products for the treatment of carcinomas and leukaemiaspharmaceutical preparations and products for the treatment of central nervous system tumours, glioblastoma, colorectal liver metastasis, squamous cell carcinomas, pancreatic cancer, melanoma, breast cancer, sarcomas, paediatric solid tumours, hepatocellular carcinoma, cancer of the eye and metastatic tumoursenhancers or super-enhancers for medical or clinical usepromoters for medical usesynthetic super enhancers in gene expression cassettes for medical or clinical useDNA sequences and RNA sequences for medical purposestransgenes for medical purposespharmaceutical preparations for use in regenerative medicines for treatment of fibrosis, age-associated disorders, senescence, rejuvenation, neurological disease, tissue injury and tissue repairgene therapy pharmaceuticalspharmaceutical preparations being vectorsbiotechnological preparations for medical usebiological compounds for use in the targeted pharmaceutical therapiesproteins with diagnostic and therapeutic useschemical and enzyme preparations for medical or veterinary purposesreagents and substances for use in testing for medical and veterinary purposesdrug delivery agents that facilitate the delivery of pharmaceutical preparationsclinical medical reagentsdiagnostic and testing preparations for clinical, medical and medical laboratory usepharmaceuticals in the field of modulating therapeuticspharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, otologic, respiratory, neurological, gastrointestinal, pancreatic, nephrologic, musculoskeletal, hormonal, dermatological, psychiatric and immune system related diseases and disordersbiological preparations for the treatment of cancerbiological preparations for use in cell cultures for medical purposesdiagnostic biomarker reagents for medical purposescells for medical or clinical useimmune cellstarget antigens for medical usevaccine preparationstherapeutic vaccines
Classe 9
Downloadable computer software programsdownloadable software, namely, lab information management systemscomputer software platformsdownloadable software for remote diagnosticsmachine learning softwaremachine learning software for use in genetic sequencingalgorithms, being computer softwarebioinformatics softwareimaging apparatus and instruments for use in the study of proteins and peptides in drug developmentdata processing softwaredownloadable computer applications in the fields of oncology, regenerative medicine, immunotherapy, recombinant protein production, immunology, cell engineering, CAR-T, viral vector engineering, genetic engineering, biopharmaceuticals, molecular biology, modulating therapeutics, assay systems, antigens and in vitro assayssoftware for predicting protein expressionsoftware in the fields of genomes, genetic mapping, molecular genetics, gene regulation, molecular biology, microbiology, pharmaceuticals, medicine, diagnostic preparations, vaccines, medicine, health, microorganisms, molecular sciences, bacteria, biochemicals, cells, stem cells, organoids, cancer stem cells, clinical trials, physiology, genetics, genomics, microbiome, metabolomics, metagenomics, proteomics, glycomics, biochemistry, therapeutics, targeted pharmaceutical therapies, bacteriology, gene expression, DNA sequencing, DNA screening, RNA sequencing, RNA screening, transgenes, biochemical reagents and biochemical assaysdownloadable computer software for scientific analysis of genetic sequencessoftware algorithms in the fields of biotechnology and modulating therapeuticssoftware as a medical deviceartificial intelligence software in the field of healthcare
Classe 41
Educação religiosa
Classe 42
Design, development and maintenance of software in the fields of genetic sequencing, genomes, genetic mapping, molecular genetics, gene regulation, molecular biology, synthetic biology, engineering biology, DNA assembly, DNA synthesis, genome editing, protein engineering, antibody engineering, microbiology, pharmaceuticals, medicine, diagnostic preparations, immunopharmaceuticals, vaccines, medicine, health, microorganisms, molecular sciences, bacteria, biochemicals, cells, stem cells, organoids, cancer stem cells, clinical trials, physiology, genetics, genomics, microbiome, metabolomics, metagenomics, proteomics, glycomics, biochemistry, therapeutics, targeted pharmaceutical therapies, bacteriology, gene expression, DNA sequencing, DNA screening, RNA sequencing, RNA screening, transgenes, biochemical reagents and biochemical assaysdesign, development and maintenance of software algorithms in the fields of biotechnology and modulating therapeuticsdesign, development and maintenance of software in the fields of oncology, regenerative medicine, immunotherapy, recombinant protein production, immunology, cell engineering, CAR-T, viral vector engineering, genetic engineering, biopharmaceuticals, molecular biology, modulating therapeutics, assay systems, antigens and in vitro assaysdesign, development and maintenance of machine learning software for use in bioinformatics, genetic sequencing, predicting protein expression, cell suppression and analysis of cell behavioursgene regulation control servicesgene regulatory network analysisanalysis, management and review of technical datadevelopment and testing of computing methods, algorithms and softwaredesign, development and maintenance of machine learning softwareresearch in the field of artificial intelligence softwaredesign and development of lab information management systemsdesign and development of software testing methodsproviding non-downloadable software for controlling, monitoring, programming and adjusting environmental conditions for cell culture, cell therapy or gene therapysoftware as a service [SaaS] platforms and tools for collecting and interpreting clinical dataplatform as a service servicescomputer aided analysis services in the field of pharmaceuticalsdatabase development and maintenance servicesdesign and development of computer platformsresearch and development services in the fields of pharmacogenetics, targeted pharmaceutical therapies and drug delivery platformsresearch and development services in the field of regenerative medicines for the treatment of fibrosis, age-associated disorders, senescence, rejuvenation, neurological disease, tissue injury and tissue repairresearch and development services in the fields of pharmaceuticals, immunopharmaceuticals, neoplastic diseases, modulating therapeutics, enhancers, super-enhancers, promoters, synthetic super enhancers in gene expression, DNA sequences, RNA sequences, fluorescent reporters, genetic cassettes, transgenes, gene therapy, drug delivery agents, vectors, diagnostic biomarker reagents, cell cultures, cell engineering, immunology and vaccinesresearch and development services in the fields of synthetic biology, engineering biology, DNA assembly, DNA synthesis, genome editing, protein engineering and antibody engineeringresearch and development services for the treatment of cancers, carcinomas, leukaemias, central nervous system tumours, glioblastoma, colorectal liver metastasis, squamous cell carcinomas, pancreatic cancer, melanoma, breast cancer, sarcomas, paediatric solid tumours, hepatocellular carcinoma, cancer of the eye and metastatic tumoursresearch and development services for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, otologic, respiratory, neurological, gastrointestinal, pancreatic, nephrologic, musculoskeletal, hormonal, dermatological, psychiatric and immune system related diseases and disordersbiological, biochemical, biomedical, bacteriological and pharmacological research, analysis, engineering and development servicesbiological laboratory servicescell engineering services, namely cell suppression, cell activation, and cell programming and reprogrammingculturing of cells for scientific or medical research purposescontract research services relating to enhancers, and super-enhancers and promotersdrug development servicesdevelopment of gene-based medicinesproviding information about medical research in the fields of biopharmaceuticals, immunology, cell engineering and immunoassaysscientific services relating to the isolation and cultivation of human tissues and cellslaboratory services namely, research, analysis, characterising, development and production of therapeutics for the treatment of neoplastic diseases, carcinomas, leukaemias, central nervous system tumours, glioblastoma, colorectal liver metastasis, squamous cell carcinomas, pancreatic cancer, melanoma, breast cancer, sarcomas, paediatric solid tumours, hepatocellular carcinoma, cancer of the eye and metastatic tumoursgenetic engineering servicesgenetic sequencing and genotyping servicesRNA sequencing servicesanalysis services regarding the safety and efficacy of new pharmaceuticalsdiagnostic services in the field of immunologypolymerase chain reaction [PCR] servicespreparation of reports in the field of biotechnologytesting of human tissues and stem cells for scientific or medical research purposesuse of biomarkers to investigate human immune response for medical purposesdesign, research, analysis and engineering services relating to genetic cassettesdesign and engineering services relating to genomic safe harbours, recombination sites, minimal promoters, insulators, splicing control elements, gene terminators, UTRs, capsids, fusion linkers, translational control elements and transcriptional unitsRNA sequence optimisation servicesevaluation services relating to RNA qualitytranslational control services in the field of gene expressiondesign of therapeutic payloadsconsultancy, information and advisory services relating to all of the aforesaid services
Publicações
Histórico de despachos e eventos da marca no INPI.
4 publicações encontradas
IPAS768
Deferimento de designação
RPI 2891
02/06/2026
IPAS900
Anotação de alteração de nome e/ou endereço em designação
Protocolo: 1973169901 (28/05/2025) Petição (tipo): Protocolo de Madri - NEWNAME
RPI 2887
05/05/2026
IPAS756
Publicação de pedido de registro para oposição (exame formal de designação concluído)
RPI 2848
05/08/2025
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ODYSSEUS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o INPI por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.